Resultado de búsqueda
A wide range of key topics are addressed, including optimal CKD evaluation and classification, kidney disease risk assessment, management of complications, medication management and drug stewardship in CKD, and strategies for delivering patient-centered care across diverse clinical settings.
- Guidelines
KDIGO Guidelines. Acute Kidney Injury (AKI) Anemia in CKD....
- Guidelines
Comparison of risk of chronic kidney disease (CKD) progression (5-year probability of estimated glomerular filtration rate [eGFR] <60 ml/min per 1.73 m 2 ) versus kidney failure in adults with CKD G1–
Current Chronic Kidney Disease (CKD) Nomenclature Used by KDIGO. CKD is defined as abnormalities of kidney structure or function, present for > 3 months, with implications for health.
Current Chronic Kidney Disease (CKD) Nomenclature Used by KDIGO. CKD is defined as abnormalities of kidney structure or function, present for >3 months, with implications for health.
Comparison of risk of chronic kidney disease (CKD) progression (5-year probability of estimated glomerular filtration rate [eGFR] <60 ml/min per 1.73 m. 2. ) versus kidney failure in adults with CKD G1–G2 calculated from the risk equation available at https://www.ckdpc.org/risk-models.html. S205.
This 2024 update of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) heralds a new era in the care of people with kidney diseases. The majority of statements from the 2012 guideline have been updated based on current knowledge and practice.
